Cite
Dolutegravir Monotherapy's Virological Efficacy in a Highly Treatment-Experienced Patient.
MLA
Lanzafame, Massimiliano, et al. “Dolutegravir Monotherapy’s Virological Efficacy in a Highly Treatment-Experienced Patient.” AIDS Research and Human Retroviruses, vol. 35, no. 4, Apr. 2019, pp. 359–60. EBSCOhost, https://doi.org/10.1089/AID.2018.0117.
APA
Lanzafame, M., Lattuada, E., Rizzardo, S., Piacentini, D., Chiesi, S., & Mazzi, R. (2019). Dolutegravir Monotherapy’s Virological Efficacy in a Highly Treatment-Experienced Patient. AIDS Research and Human Retroviruses, 35(4), 359–360. https://doi.org/10.1089/AID.2018.0117
Chicago
Lanzafame, Massimiliano, Emanuela Lattuada, Sebastiano Rizzardo, Daniela Piacentini, Sheila Chiesi, and Romualdo Mazzi. 2019. “Dolutegravir Monotherapy’s Virological Efficacy in a Highly Treatment-Experienced Patient.” AIDS Research and Human Retroviruses 35 (4): 359–60. doi:10.1089/AID.2018.0117.